(Reuters) - A new type of asthma drug meant to attack the underlying causes of the respiratory disease slashed episodes by 87 percent in a mid-stage trial, making it a potential game changer for patients with moderate to severe disease, researchers said on Tuesday. Full story
Before students at John M. Sexton Elementary can get their groove on to Beyonce songs during gym class, they stop by the Nurse's Office to test their lung capacity. It's just part of a school wide Asthma initiative. The nurse helps students with a Peak Flow Meter, a device that measures breathing. Full story
NEW YORK (Reuters Health) - Toddlers are less likely to have asthma and itchy rashes if their parents "cleaned" their pacifiers by sucking on them when the kids were infants, a small new study suggests. Full story
LONDON (Reuters) - Britain's health cost-effectiveness watchdog NICE said it planned to recommend the use of Novartis's severe asthma drug Xolair after prevaricating for months over whether it should be paid for on the taxpayer-funded National Health Service (NHS). Full story
After having a bad reaction to medication for an asthma attack, doctors struggle to treat a woman with a mysterious disease; her hair follicles now sprout fingernail-like growths. WMC's Anna Marie Hartman reports.